Usted buscó: venous (Francés - Inglés)

prevention of venous thromboembolic
b01ae prevention of venous thromboembolic events in

venous thromboembolism in cancer patients:
grand'maison, anne venous thromboembolism in cancer patients:

les chiffres ci-dessous illustrent ce que nous venous de dire.
let us cite statistics to illustrate these points.

b01ae prevention of venous thromboembolic events in patients undergoing major
b01ae prevention of venous thromboembolic events in

thromboprophylaxis to prevent venous thromboembolism among patients undergoing hip and knee arthroplasty
identification of genes conferring susceptibility to defined subtypes of familial alcoholism

health system capacity and infrastructure for adopting innovations in venous thromboembolic disease care
fibroproliferative disorders of the skin:

incident and management of deep venous thrombosis and pulmonary emboli», transpl.
incident and management of deep venous thrombosis and pulmonary emboli.

the graft is particularly useful as an arterial-venous graft for hemodialysis procedures
the graft is particularly useful as an arterial-venous graft for hemodialysis procedures.

c linical investigation of medicinal products for the treatment of venous thrombo-embolic d isease
clinical investigation of medicinal products for treatment of venous thrombo-embolic disease

d-dimer to select patients with a first unprovoked venous thromboembolism who can have anticoagulants stopped at 3 months
agree next steps, phase ii. continuous quality improvement in the evaluation of clinical practice guidelines

risk-benefit ratio of extended thromboprophylaxis to prevent venous thromboembolism among patients undergoing hip or knee replacement surgery:
the functions of dendritic spine shape and motility in the hippocampus

c linical investigation of medicinal products for prophylactic the treatment of peri- and post-operative venous thrombo-embolic risk
clinical investigation of medicinal products for prophylactic treatment of peri- and post-operative venous thrombo- embolic risk

s01ex reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension b01ae prevention of venous thromboembolic events in patients undergoing major orthopaedic surgery
· s01ex · reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension · b01ae · prevention of venous thromboembolic events in patients undergoing major orthopaedic surgery · b01ae · prevention of venous thromboembolic events in patients undergoing major orthopaedic surgery · b03xa · treatment of anaemia in patients with chronic renal failure

loop, endarterectomy shunt, intraocular shunt, peritoneal (peritoneo-venous) shunt, pleuro-peritoneal
loop, endarterectomy shunt, intraocular shunt, peritoneal (peritoneo -venous) shunt, pleuro-peritoneal

determining the risk of fetal loss in women with unprovoked venous thromboembolism(vte) who do not have identifiable inherited thromophilia compared with women who have the diagnosis of vte excluded.
crystallographic studies of dna repair proteins involved in non-homologous dna end joining

ghali, william a university of calgary health system capacity and infrastructure for adopting innovations in venous thromboembolic disease care giaid, adel université mcgill hôpital général de montréal role of urotensin-ii in congestive heart failure
** prc = peer review committee. a legend to the committee codes appears at the end of this list.

this would be the case during pulmonary uptake or elimination of a solvent, which would cause differences in concentration between capillary blood (mainly arterial blood) and venous blood.
the concentration of the generated atmosphere should be verified either by well characterized gravimetric/volumetric means or by analysis of replicate samples (if possible) by an independent method at each concentration used.

il convient de relever que les preuves fournies par l’intervenante à la division d’opposition concernant l’usage, en finlande, de la marque capiox sont les suivantes : – en annexe i au dossier de l’ohmi : – deux brochures publicitaires pour le capiox® sx series oxygenators en anglais datées d’avril 1999 et de 2000, incluant chacune des brochures pour le capiox® sx 10, le capiox® sx 18 et le capiox® sx 25 ; deux brochures publicitaires pour le capiox® hemoconcentrator hc 11/hc 05 en anglais datées de juin 1999 et de 2000 ; une brochure publicitaire pour le capiox® arterial filter for pediatric use en anglais datée de 2000 ; une brochure publicitaire pour le xcoating™ capiox® adult arterial filter en anglais datée de 2000 ; une brochure publicitaire pour le capiox® arterial filter af 125 en anglais datée de mai 2002 ; une brochure publicitaire pour le capiox® bubble trap en anglais datée de 2000 ; une brochure publicitaire pour le capiox® cardioplegia en anglais datée de 2001 ; une brochure publicitaire pour la capiox® sp pump en anglais datée de 1997 ; une brochure publicitaire pour le capiox® venous reservoir en anglais datée de 1998 ; une brochure publicitaire pour le xcoating™ for capiox® and sarns™ perfusion circuit products en anglais datée de 2000 ; une brochure publicitaire pour le capiox® cardiotomy reservoir and hardshell venous reservoir en anglais datée de 2000 ; une brochure publicitaire pour le capiox® ii hollow fiber oxygenator with integrated heat exchanger en anglais datée de 1983 ; une brochure publicitaire pour le capiox® rx 25 with xcoating™ en anglais datée de 2003 ;
it must be noted that the intervener submitted the following evidence to the opposition division concerning use of the trade mark capiox in finland: – in annex i to the ohim file: – two advertising brochures for the capiox® sx series oxygenators in english, dated april 1999 and 2000, each including brochures for the capiox® sx 10, the capiox® sx 18 and the capiox® sx 25; two advertising brochures for the capiox® hemoconcentrator hc 11/hc 05 in english, dated june 1999 and 2000; one advertising brochure for the capiox® arterial filter for pediatric use in english, dated 2000; one advertising brochure for the xcoating™ capiox® adult arterial filter in english, dated 2000; one advertising brochure for the capiox® arterial filter af 125 in english, dated may 2002; one advertising brochure for the capiox® bubble trap in english, dated 2000; one advertising brochure for the capiox® cardioplegia in english, dated 2001; one advertising brochure for the capiox® sp pump in english, dated 1997; one advertising brochure for the capiox® venous reservoir in english, dated 1998; one advertising brochure for the xcoating™ for capiox® and sarns™ perfusion circuit products in english, dated 2000; one advertising brochure for the capiox® cardiotomy reservoir and hardshell venous reservoir in english, dated 2000; one advertising brochure for the capiox® ii hollow fiber oxygenator with integrated heat exchanger in english, dated 1983; one advertising brochure for the capiox® rx 25 with xcoating™ in english, dated 2003; one advertising brochure for the mini rx™ reduced prime perfusion circuit with xcoating™ in english, dated 2003; six advertising brochures for the capiox® rx 05 baby-rx™ with xcoating™, two in english, dated 2000 and 2003, one in french, one in german, one in spanish and one in cyrillic script, dated 2003; two identical advertising brochures for the capiox® rx 25 xcoating in english, dated 2000; a product catalogue in english compiled in 2004; twelve labels all bearing the word capiox® concerning products with the following codes: